exciting times for hormone-sensitive prostate cancer treatment
Published 1 year ago • 105 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:17
treatment landscape for metastatic hormone-sensitive prostate cancer
-
3:44
the evolving standard of care for patients with metastatic hormone-sensitive prostate cancer
-
1:56
arasens: dialuramide plus adt and docetaxel for metastatic hormone-sensitive prostate cancer
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
0:47
systemic triple therapy in metastatic hormone-sensitive prostate cancer
-
3:20
radiation therapy for the local treatment of metastatic hormone-sensitive prostate cancer
-
4:05
evaluating triplet therapy in metastatic hormone sensitive prostate cancer
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
3:55
selecting treatment for hormone-sensitive prostate cancer
-
3:13
prostate cancer: treatment sequencing and choice
-
2:25
subgroups of metastatic hormone-sensitive prostate cancer (mhspc)
-
2:27
triplet therapy for metastatic hormone-sensitive prostate cancer
-
13:09
pca commentary: metastatic hormone sensitive prostate cancer (mhspc): many treatment options
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
6:53
perspectives on metastatic hormone-sensitive prostate cancer | bayer
-
17:44
new approaches to metastatic hormone sensitive prostate cancer
-
3:57
update on arches trial: implications for prostate cancer treatment